Single-cell analysis of the lung immune microenvironment and cell-cell interactions across healthy and diseased patients
Single-cell analysis of the lung immune microenvironment and cell-cell interactions across healthy and diseased patients
批准号:
10472702
负责人:
Alexander Minchev Tsankov
金额:
$12.68万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-20 至 2023-07-31
关键词:
AccountingAgeAnatomyAsthmaAtlasesBiologyCell CommunicationCell physiologyCellsCensusesCessation of lifeChronic lung diseaseClinicalClinical DataClinical TrialsCollaborationsCommunicationCommunitiesComplexComputer AnalysisComputing MethodologiesDataDiseaseDistalDropoutEventFluorescenceFutureGenderHealthHomeostasisHumanImmunityIndividualLaboratoriesLigandsLocationLungLung diseasesMethodsOrganPathogenesisPathogenicityPathway interactionsPatientsPositioning AttributeProtocols documentationResearchResolutionResourcesRespiratory SystemRoleSmokingSmoking HistorySmoking StatusStructure of parenchyma of lungTechnologyTestingTissuesVariantVisualizationanalysis pipelineasthmatic patientbasecell typeclinical effectcomputer frameworkdata integrationhigh dimensionalityimprovedinfancymultidimensional datanovelreceptorsingle cell analysissingle cell technologysingle-cell RNA sequencingtargeted treatmenttherapeutic targettissue processingtooltumor-immune system interactions
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Lung diseases, such as asthma, are believe to arise due to alterations in cell type proportion, cellular function,
and tissue organization in different compartments of the respiratory system. Recent advances in high-
throughput single cell RNA-sequencing (scRNA-seq) have enabled comprehensive characterization of the
cellular census of the lung, which has led to a remarkable number of novel findings in new cell types and cell
states at homeostasis and in disease, including our team’s recent discovery of the pulmonary ionocyte.
However, our understanding of the cell type relationships and their higher order tissue organization is still
lacking in the context of health and disease. In 2020, over 1 million cells of scRNA-seq data from healthy and
diseased lung patients will become available, which will provide unprecedented resolution and statistical power
to study the variation in the lung microenviroment across different anatomical locations in healthy and diseased
individuals. Such an endeavor presents several computational challenges due to the high-dimensionality of the
data and because analysis tools of cellular communication in scRNA-seq data and integration with spatial
information are still at their infancy. We propose to integrate high-dimensional scRNA-seq data and correct for
batch effects between laboratories in order to build a uniformly annotated single-cell atlas of more than one
hundred healthy and asthma patients. Such an atlas would enable us to characterize the similarities and
differences in cellular composition and cell-cell interactions at different locations along the proximal-distal axis
of the healthy human lung and assess the effects of clinical correlates, such as age and smoking history, on
cellular composition and organization. Location specific lung microenvironment analysis is critical to
understand the context of lung disease pathogenesis, especially in the context of asthma. Furthermore,
comparison between the lung microenvironment in anatomically matched regions across hundreds of normal
and asthma patients will uncover commonly dysregulated cellular proportions and cell-cell interactions that can
inform on shared pathways to target therapeutically. Beyond the scope of this study, we aim to validate the
newly discovered cell-cell interactions using sequence- or fluoresce-based spatial data, that is available to our
lab through the Human Cell Atlas network and through our ongoing collaborations at Mount Sinai.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative, single-cell analysis of COVID-19 and other respiratory diseases
-
批准号:10361031
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2022
-
负责人:Alexander Minchev Tsankov
-
依托单位:
Comparative, single-cell analysis of COVID-19 and other respiratory diseases
-
批准号:10549811
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2022
-
负责人:Alexander Minchev Tsankov
-
依托单位:
Decoding the cellular mechanisms of COVID-19 severe disease susceptibility in patients with chronic respiratory disease
-
批准号:10185342
-
项目类别:
-
资助金额:$83.95万
-
财政年份:2021
-
负责人:Alexander Minchev Tsankov
-
依托单位:
Single-cell analysis of the lung immune microenvironment and cell-cell interactions across healthy and diseased patients
-
批准号:10293348
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2021
-
负责人:Alexander Minchev Tsankov
-
依托单位:
Uncovering the transcription factor networks in early human cell specification
-
批准号:8526759
-
项目类别:
-
资助金额:$5.49万
-
财政年份:2013
-
负责人:Alexander Minchev Tsankov
-
依托单位:
Uncovering the transcription factor networks in early human cell specification
-
批准号:8625642
-
项目类别:
-
资助金额:$5.62万
-
财政年份:2013
-
负责人:Alexander Minchev Tsankov
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: